Verpleegkundigen lopen in de gangVerpleegkundigen in gesprek met patiëntVerpleegkundigen in gesprek met patiënt
Siemerink, E.J.M.

mw. dr. E.J.M. Siemerink

Afspraak maken?

Overige informatie

Meer informatie over interactieve liveoperatie: borstsparende operatie en reconstructie

Aandachtsgebieden

  • Interne geneeskunde
  • Oncologie

Nevenfuncties

  • Portefeuillehouder CMS Ketenzorg & HR

BIG-nummer

19056402101

Wetenschappelijke publicaties en onderzoeken

  • A holistic profile for cancer-related fatigue for women with breast cancer - a qualitative study

    Wijlens KAE, Beenhakker L, Witteveen A, Siemerink EJM, Jansen L, Gernaat C, Schellekens MPJ, Siesling S, Vollenbroek-Hutten MMR, Bode C.
    Psychol Health. 2025; 40(6):1037-1061.

  • The Added Value of Physical Examination for Breast Cancer Recurrence Detection in Women: A Systematic Review

    Godding LTH, Dekker-Klaassen A, Volders HJ, Hezewijk M van, Siemerink EJM, Uden D van, Veltman J, Eijkelboom AH, Siesling S.
    Clin Breast Cancer 2025; 25(4):E393.e2.

  • Clinical Relevance of Immunohistochemical Subtypes in Early-Stage, Lymph Node-negative Breast Cancer. Results of a Large Cohort Study

    Jobsen JJ, Struikmans H, Siemerink EJM, Palen J van der.
    Clin Oncol (R Coll Radiol) 2025; :Doi: 10.1016/j.clon.2025.103786. Epub 2025 Feb 7..

  • MRI-guided optimisation of neoadjuvant chemotherapy duration in stage II-III HER2-positive breast cancer (TRAIN-3): a multicentre, single-arm, phase 2 study

    Voort A van der , Louis FM, Ramshorst MS van, Kessels R, Mandjes IA, Kemper I, Agterof MJ, Steeg WA van der, Heijns JB, Bekkum ML van, Siemerink EJM.
    Clinical Trial Lancet Oncol. 2024; 25(5):603-13.

  • The effectiveness of personalised surveillance and aftercare in breast cancer follow-up: a systematic review

    Maaren MC van , Hoeve JC van, Korevaar JC, Hezewijk M van, Zeillemaker AM, Siemerink EJM, Klaasen-Dekker A, Uden DJP van, Volders JH, Drossaert CHC, Siesling S.
    Support Care Cancer 2024; 32(5):323.

  • Limited Impact of Breast Cancer and Non-breast Malignancies on Survival in Older Patients with Early-Stage Breast Cancer: Results of a Large, Single-Centre, Population-Based Study

    Jobsen JJ, Palen J van der, Siemerink EJM, Struikmans H.
    Clin Oncol (R Coll Radiol). 2022; 34(6):355-362.

  • The Mitotic Activity Index in combination with Her2neu: a strong prognosticator in breast cancer

    Jobsen JJ, Struikmans H, Palen JJ van der , Siemerink EJM.
    Breast Cancer Res Treat. 2020; 181(1):13-21.

  • Breast-conserving therapy in older patients with breast cancer over three decades: progress or stagnation.

    Jobsen JJ, Middelburg JG, Palen J van der , Riemersma S, Siemerink EJM, Struikmans H, Siesling S.
    J Geriatr Oncol. 2018; :doi: 10.1016/j.jgo.2018.08.007. [Epub ahead of print].
    Publicatie openen

  • Capecitabine-based treatment of a patient with a novel DPYD genotype and complete dihydropyrimidine dehydrogenase deficiency

    Henricks LM, Siemerink EJM, Rosing H, Meijer J, Goorden SM, Polstra AM, Zoetekouw L, Cats A, .
    Int J Cancer. 2018; 142(2):424-430.

  • Preoperative chemoradiotherapy in locally advanced gastric cancer, a phase I/II feasibility and efficacy study

    Trip AK, Poppema BJ, Berge Henegouwen MI van, Siemerink EJM, Beukema JC, Verheij M, Plukker JT, Richel DJ, Hulshof MC, Sandick JW van, Cats A, Jansen EP, Hospers .
    Radiother Oncol 2014; 112(2):284-8.
    Publicatie openen